现场表现和公共卫生应对：在社区检测中使用 BinaxNOWTM 快速严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）抗原检测试剂盒。
Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing.
机构信息
Department of Pathology, Stanford University, Palo Alto, California, USA.
Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California, USA.
出版信息
Clin Infect Dis. 2021 Nov 2;73(9):e3098-e3101. doi: 10.1093/cid/ciaa1890.
Among 3302 persons tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by BinaxNOWTM and reverse transcription polymerase chain reaction (RT-PCR) in a community setting, rapid assay sensitivity was 100%/98.5%/89% using RT-PCR cycle thresholds of 30, 35, and no threshold. The specificity was 99.9%. Performance was high across ages and those with and without symptoms. Rapid resulting permitted immediate public health action.
在社区环境中，使用 BinaxNOWTM 和逆转录聚合酶链反应（RT-PCR）对 3302 人进行了严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）检测，快速检测的灵敏度分别为 30、35 和无阈值 RT-PCR 循环阈值时为 100%/98.5%/89%。特异性为 99.9%。在各个年龄段以及有症状和无症状人群中的表现都很高。快速的结果可以立即采取公共卫生措施。
Zotero 插件